| Lastest Insider Transactions Of CymaBay Therapeutics, Inc. ( CBAY ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| CBAY | CymaBay Therapeutics, Inc. | Shah Sujal | Chief Executive Officer | 2024-03-13 | Option Exercise | 139,119 | 4.72 | 655,959 | 2024-03-15 16:03:54 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2024-03-13 | Option Exercise | 41,824 | 7.89 | 329,991 | 2024-03-15 16:02:17 |
| CBAY | CymaBay Therapeutics, Inc. | Dorling Janet | Directior | 2024-02-12 | Sell | 6,000 | 31.97 | 191,849 | 2024-02-14 18:43:24 |
| CBAY | CymaBay Therapeutics, Inc. | Dorling Janet | Directior | 2024-02-12 | Option Exercise | 6,000 | 4.63 | 27,780 | 2024-02-14 18:43:24 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2024-01-19 | Sell | 18,403 | 23.67 | 435,645 | 2024-01-22 18:59:20 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2024-01-19 | Option Exercise | 18,403 | 7.09 | 130,522 | 2024-01-22 18:59:20 |
| CBAY | CymaBay Therapeutics, Inc. | Menold Daniel | Vice President, Finance | 2024-01-16 | Sell | 10,000 | 23.58 | 235,806 | 2024-01-16 19:07:39 |
| CBAY | CymaBay Therapeutics, Inc. | Menold Daniel | Vice President, Finance | 2024-01-16 | Option Exercise | 10,000 | 4.05 | 40,500 | 2024-01-16 19:07:39 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2024-01-16 | Sell | 5,000 | 23.58 | 117,898 | 2024-01-16 19:07:09 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2024-01-16 | Option Exercise | 5,000 | 2.94 | 14,700 | 2024-01-16 19:07:09 |
| CBAY | CymaBay Therapeutics, Inc. | Dorling Janet | Directior | 2024-01-10 | Sell | 6,000 | 23.86 | 143,144 | 2024-01-10 20:35:04 |
| CBAY | CymaBay Therapeutics, Inc. | Dorling Janet | Directior | 2024-01-10 | Option Exercise | 6,000 | 4.63 | 27,780 | 2024-01-10 20:35:04 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-12-18 | Sell | 11,332 | 21.48 | 243,441 | 2023-12-18 20:04:25 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-12-18 | Option Exercise | 11,332 | 5.00 | 56,660 | 2023-12-18 20:04:25 |
| CBAY | CymaBay Therapeutics, Inc. | Menold Daniel | Vice President, Finance | 2023-12-15 | Sell | 21,497 | 21.99 | 472,647 | 2023-12-15 16:38:12 |
| CBAY | CymaBay Therapeutics, Inc. | Menold Daniel | Vice President, Finance | 2023-12-15 | Option Exercise | 21,497 | 6.39 | 137,420 | 2023-12-15 16:38:12 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-12-15 | Sell | 5,000 | 21.98 | 109,903 | 2023-12-15 16:35:37 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-12-15 | Option Exercise | 5,000 | 2.94 | 14,700 | 2023-12-15 16:35:37 |
| CBAY | CymaBay Therapeutics, Inc. | Shah Sujal | Chief Executive Officer | 2023-12-11 | Sell | 64,865 | 20.00 | 1,297,170 | 2023-12-11 19:03:17 |
| CBAY | CymaBay Therapeutics, Inc. | Shah Sujal | Chief Executive Officer | 2023-12-11 | Option Exercise | 64,865 | 5.00 | 324,325 | 2023-12-11 19:03:17 |
| CBAY | CymaBay Therapeutics, Inc. | Dorling Janet | Directior | 2023-12-11 | Sell | 6,000 | 20.07 | 120,422 | 2023-12-11 19:01:33 |
| CBAY | CymaBay Therapeutics, Inc. | Dorling Janet | Directior | 2023-12-11 | Option Exercise | 6,000 | 4.63 | 27,780 | 2023-12-11 19:01:33 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-11-17 | Sell | 11,342 | 18.28 | 207,293 | 2023-11-17 17:58:05 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-11-17 | Option Exercise | 11,342 | 5.00 | 56,710 | 2023-11-17 17:58:05 |
| CBAY | CymaBay Therapeutics, Inc. | Menold Daniel | Vice President, Finance | 2023-11-15 | Option Exercise | 17,500 | 3.45 | 60,375 | 2023-11-17 17:57:34 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-11-15 | Sell | 5,000 | 17.38 | 86,889 | 2023-11-17 17:57:10 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-11-15 | Option Exercise | 5,000 | 2.94 | 14,700 | 2023-11-17 17:57:10 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-10-18 | Sell | 21,743 | 14.07 | 305,941 | 2023-10-18 18:22:34 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-10-18 | Option Exercise | 21,743 | 5.00 | 108,715 | 2023-10-18 18:22:34 |
| CBAY | CymaBay Therapeutics, Inc. | Menold Daniel | Vice President, Finance | 2023-10-16 | Option Exercise | 17,500 | 3.45 | 60,375 | 2023-10-18 18:22:08 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-10-16 | Sell | 5,000 | 13.76 | 68,798 | 2023-10-18 18:21:37 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-10-16 | Option Exercise | 5,000 | 2.94 | 14,700 | 2023-10-18 18:21:37 |
| CBAY | CymaBay Therapeutics, Inc. | Shah Sujal | Chief Executive Officer | 2023-10-09 | Sell | 64,861 | 14.20 | 921,286 | 2023-10-10 17:04:11 |
| CBAY | CymaBay Therapeutics, Inc. | Shah Sujal | Chief Executive Officer | 2023-10-09 | Option Exercise | 64,861 | 5.00 | 324,305 | 2023-10-10 17:04:11 |
| CBAY | CymaBay Therapeutics, Inc. | EMSTER KURT VON | Directior | 2023-09-29 | Sell | 15,921 | 15.68 | 249,675 | 2023-09-29 17:54:02 |
| CBAY | CymaBay Therapeutics, Inc. | EMSTER KURT VON | Directior | 2023-09-29 | Option Exercise | 15,921 | 5.00 | 79,605 | 2023-09-29 17:54:02 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-09-18 | Sell | 21,746 | 16.22 | 352,733 | 2023-09-19 17:27:46 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-09-18 | Option Exercise | 21,746 | 5.00 | 108,730 | 2023-09-19 17:27:46 |
| CBAY | CymaBay Therapeutics, Inc. | Menold Daniel | Vice President, Finance | 2023-09-15 | Option Exercise | 16,545 | 1.73 | 28,612 | 2023-09-19 17:25:42 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-09-15 | Sell | 53,000 | 16.87 | 894,141 | 2023-09-19 17:23:45 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-09-15 | Option Exercise | 53,000 | 2.94 | 155,820 | 2023-09-19 17:23:45 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-08-18 | Sell | 21,746 | 11.47 | 249,359 | 2023-08-18 19:03:13 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-08-18 | Option Exercise | 21,746 | 5.00 | 108,730 | 2023-08-18 19:03:13 |
| CBAY | CymaBay Therapeutics, Inc. | Menold Daniel | Vice President, Finance | 2023-08-15 | Option Exercise | 15,500 | 5.10 | 79,010 | 2023-08-16 16:59:50 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-08-15 | Sell | 5,000 | 11.91 | 59,551 | 2023-08-16 16:57:19 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-08-15 | Option Exercise | 5,000 | 2.94 | 14,700 | 2023-08-16 16:57:19 |
| CBAY | CymaBay Therapeutics, Inc. | Menold Daniel | Vice President, Finance | 2023-08-09 | Sell | 20,945 | 12.35 | 258,744 | 2023-08-11 18:26:48 |
| CBAY | CymaBay Therapeutics, Inc. | Menold Daniel | Vice President, Finance | 2023-08-09 | Option Exercise | 20,945 | 5.00 | 104,725 | 2023-08-11 18:26:48 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-07-18 | Sell | 21,749 | 11.43 | 248,519 | 2023-07-19 18:05:31 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-07-18 | Option Exercise | 21,749 | 5.00 | 108,745 | 2023-07-19 18:05:31 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-07-14 | Sell | 5,000 | 11.81 | 59,050 | 2023-07-14 18:52:36 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-07-14 | Option Exercise | 5,000 | 2.94 | 14,700 | 2023-07-14 18:52:36 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-06-30 | Sell | 5,000 | 10.05 | 50,250 | 2023-06-30 16:51:25 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-06-30 | Option Exercise | 5,000 | 2.94 | 14,700 | 2023-06-30 16:51:25 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-06-20 | Sell | 21,749 | 8.16 | 177,383 | 2023-06-21 18:46:06 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-06-20 | Option Exercise | 21,749 | 5.00 | 108,745 | 2023-06-21 18:46:06 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-05-18 | Sell | 21,749 | 9.08 | 197,387 | 2023-05-19 18:00:14 |
| CBAY | CymaBay Therapeutics, Inc. | McWherter Charles | President of R&D | 2023-05-18 | Option Exercise | 21,749 | 5.00 | 108,745 | 2023-05-19 18:00:14 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-05-15 | Sell | 5,000 | 10.37 | 51,831 | 2023-05-17 19:11:15 |
| CBAY | CymaBay Therapeutics, Inc. | Quinlan Paul T | General Counsel | 2023-05-15 | Option Exercise | 5,000 | 2.94 | 14,700 | 2023-05-17 19:11:15 |
| CBAY | CymaBay Therapeutics, Inc. | KIM DENNIS D | Chief Medical Officer | 2023-04-13 | Sell | 120,000 | 9.50 | 1,140,416 | 2023-04-17 19:24:09 |
| CBAY | CymaBay Therapeutics, Inc. | KIM DENNIS D | Chief Medical Officer | 2023-04-13 | Option Exercise | 120,000 | 4.37 | 524,400 | 2023-04-17 19:24:09 |
| CBAY | CymaBay Therapeutics, Inc. | KIM DENNIS D | Chief Medical Officer | 2023-03-28 | Sell | 100 | 8.98 | 899 | 2023-03-30 17:39:49 |
| CBAY | CymaBay Therapeutics, Inc. | KIM DENNIS D | Chief Medical Officer | 2023-03-28 | Option Exercise | 100 | 4.37 | 437 | 2023-03-30 17:39:49 |
